Use of interleukin-11 to prevent immune-mediated cytotoxicity

Details Use of interleukin-11 to prevent immune-mediated cytotoxicity Use of interleukin-11 to prevent immune-mediated cytotoxicity

2005-10-11

2005-10-11

Andres, Janet (Department: 1647)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600, C514S008100, C514S885000, C424S085100, C424S085200

Reexamination Certificate

active

06953777

ABSTRACT:
The use of interleukin-11 to prevent, to ameliorate, and to treat an immune-mediated disease in a mammal in need of such treatment is disclosed.

REFERENCES:
patent: 4518584 (1985-05-01), Mark et al.
patent: 5215895 (1993-06-01), Bennett et al.
patent: 5270181 (1993-12-01), McCoy et al.
patent: 5292646 (1994-03-01), McCoy et al.
patent: 5460810 (1995-10-01), Williams et al.
patent: 5496830 (1996-03-01), Shapiro et al.
patent: 5582821 (1996-12-01), Kaye
patent: 5631219 (1997-05-01), Rosenthal et al.
patent: 5679339 (1997-10-01), Keith et al.
patent: 5700664 (1997-12-01), Yang et al.
patent: 5846958 (1998-12-01), Capizzi et al.
patent: 5854028 (1998-12-01), Yang et al.
patent: 6066317 (2000-05-01), Yang et al.
patent: 6126933 (2000-10-01), Warne et al.
patent: WO 92/04455 (1992-03-01), None
patent: WO 96/19574 (1996-06-01), None
patent: WO 97/01353 (1997-01-01), None
patent: WO 99/37322 (1999-07-01), None
patent: WO 00/74707 (2000-12-01), None
Hill et al., Interleukin-11 Promotes T Cell Polarization and Prevents Acute Graft-Versus_Host Disease after Allogeneic Bone Marrow Transplantation. J.Clin.Invest. vol. 102 (1),115-123.
Hill,IL-11 Promotes T Cell Polarization and Prevents Acute Graft Versus Host Disease After Allogeneic Bone Marrow Transplantation,1998, J Clin Invest 102: 115-23.
Biederman,Human Endothelial Cells Induce and Regulate Cytolytic T Cell Differentiation,1998, J Immunol 161: 4679-87.
Du,Protective Effects of Interleukin-11 in a Murine Model of Ischemic Bowel Necrosis,1997, Am J Physiol 272: G545.
Orazi,Interleukin-11 Prevents Apoptosis and Accelerates Recovery of Small Intestinal Mucosa in Mice Treated with Combined Chemotherapy and Radiation,1996, Lab Invest 75: 33.
Redlich,IL-11 Enhances Survival and Decreases TNF Production After Radiation-induced Thoracic injury,1996, J Immunol 157: 1705.
Trepicchio,IL-11 Regulates Macrophage Effector Function Through the Inhibition of Nuclear Factor-8B,1997, J Immunol: 5661.
Yang,Interleukin(IL)-11-mediated Signal Transduction,1995, Ann NY Acad Sci 762: 31.
Miyatake,Complement-fixing Elicited Antibodies are a Major Component in the Pathogenesis of Xenograft Rejection,1998, J Immunol 160: 4114.
Boulton,STAT3 Activation by Cytokines Utilizing gp130 and Related Transducers Involoves a Secondary Modification Requiring an H7-sensitive Kinase,1995, Proc Natl Acad Sci USA 92: 6915.
Pober,The Role of Endothelial Cells in Inflammation,1990, Transplantation 50: 537.
Johnson,A Sustained Reduction in I 8B-2 May Contribute to Persistent NF-8B Activation in Human Endothelial Cells,1996, J Biol Chem 271: 16317.
Ambrosini,A Novel Anti-apoptosis Gene, Survivin, Expressed in Cancer and Lymphoma,1997, Nat Med 3: 917-21.
Reed,Survivin' Cell-separation Anxiety,1999, Nat Cell Biol 1: E199-200.
Chen,Interleukin-6 Inhibits Transforming Growth Factor-2-induced Apoptosis through the Phosphatidylinositol 3-Kinase/Akt and Signal Transducers and Activators of Transcription 3 Pathways,1999, J Biol Chem 274: 23013-19.
Tran,Marked Induction of the IAP Family Antiapoptotic Proteins Survivin and XIAP by VEGF in Vascular Endothelial Cells,1999, Bioch m Biophys Res Commun 264: 781-88.
Fukada,Two Signals are Necessary for Cell Proliferation Induced by a Cytokine Receptor gp130: Involvement of STAT3 in Anti-Apoptosis,1996, Immunity 5: 449-60.
Mantell,Hyperoxia-induced Cell Death in the Lung—the Correlation of Apoptosis, Necrosis, and Inflammation,1999, Ann NY Acad Sci 887: 171-80.
Dorner et al., Interleukin-11, Biological Activity and Clinical Studies. BioDrugs, 8(6):418-29. (Dec. 1997).

Affiliated with

Also associated with

Rating

Use of interleukin-11 to prevent immune-mediated cytotoxicity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of interleukin-11 to prevent immune-mediated cytotoxicity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of interleukin-11 to prevent immune-mediated cytotoxicity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3452155